One-liner#
Distinguish hypertensive urgency (severely elevated BP without acute end-organ damage) from hypertensive emergency (end-organ damage requiring ED), then safely lower BP over hours to days in the office while addressing underlying causes and optimizing long-term control.
Quick nav#
- Red flags / send to ED
- Key history
- Focused exam
- Differential (quick pattern recognition)
- Workup
- Initial management
- Management by diagnosis
- Follow-up
- Patient instructions
- Smartphrase snippets
- Related pages
Red flags / send to ED#
- Neurologic: severe headache, altered mental status, focal deficits, seizure, visual changes (hypertensive encephalopathy, stroke, PRES)
- Cardiac: chest pain, dyspnea, pulmonary edema (ACS, acute HF, aortic dissection)
- Renal: oliguria, hematuria, rapidly rising creatinine (acute kidney injury)
- Vascular: tearing chest/back pain, pulse deficits, BP differential between arms (aortic dissection)
- Obstetric: pregnancy with severe HTN (preeclampsia/eclampsia—out of scope but recognize and transfer)
- Fundoscopic: papilledema, flame hemorrhages, exudates (malignant hypertension)
- BP >180/120 with ANY of the above = hypertensive emergency → ED
Key history#
Confirm the reading:
- Proper technique: seated 5 min, back supported, feet flat, arm at heart level, appropriate cuff size
- Repeat measurement after 5 minutes of rest
- Check both arms if first encounter or concern for dissection
Characterize the presentation:
- Asymptomatic vs symptomatic
- Acute rise vs chronic severe HTN
- Known hypertension history and baseline BP
- Recent BP readings (home, pharmacy, prior visits)
Identify precipitants:
- Medication non-adherence (most common cause)
- Ran out of medications / insurance/cost issues
- Recent medication changes or discontinuation
- Dietary indiscretion (high salt)
- Acute pain, anxiety, panic
- Substance use: cocaine, amphetamines, phencyclidine
- OTC medications: NSAIDs, decongestants (pseudoephedrine), diet pills
- Herbal supplements: licorice, ephedra, ginseng
- Withdrawal: alcohol, clonidine, beta-blockers
Screen for end-organ damage symptoms:
- Neurologic: headache, vision changes, confusion, weakness, numbness
- Cardiac: chest pain, dyspnea, orthopnea, palpitations
- Renal: decreased urine output, hematuria, flank pain
Relevant history:
- HTN duration and usual control
- Current antihypertensive regimen and adherence
- Prior hypertensive crises
- Comorbidities: CKD, CAD, HF, stroke, diabetes
- Secondary HTN history: OSA, renal artery stenosis, pheochromocytoma, primary aldosteronism
Focused exam#
- Vitals: BP both arms (manual preferred for accuracy), HR, RR, O2 sat
- General: distress level, diaphoresis, anxiety
- Neurologic: mental status, cranial nerves, motor/sensory, gait (if safe)
- Fundoscopic: papilledema, hemorrhages, exudates, AV nicking (if equipment/skill available)
- Cardiac: JVD, S3/S4, murmurs (AR in dissection), displaced PMI
- Pulmonary: crackles (pulmonary edema)
- Abdominal: bruits (renal artery stenosis), pulsatile mass (AAA)
- Extremities: peripheral pulses, edema
Differential (quick pattern recognition)#
Common/likely (outpatient)#
| Diagnosis | Keywords patients use | Key clues | Focused exam clues | Initial next step |
|---|---|---|---|---|
| Medication non-adherence | “Ran out,” “can’t afford,” “forgot” | Known HTN; missed doses; no symptoms | Elevated BP; otherwise normal exam | Restart/reinforce meds; address barriers; observe in office |
| White coat hypertension | “Always high at doctor” | Normal home readings; anxious in office | Elevated BP; no end-organ signs | Home BP monitoring; ambulatory BP monitoring if uncertain |
| Pain-induced HTN | “Hurts,” “in pain” | Acute pain from any cause | Elevated BP normalizes when pain controlled | Treat underlying pain; recheck BP |
| Anxiety/panic | “Stressed,” “anxious,” “heart racing” | Situational; hyperventilation; palpitations | Tachycardia; elevated BP; no end-organ signs | Reassurance; recheck after calming; consider anxiolytic |
| Rebound HTN | “Stopped my clonidine” | Recent discontinuation of clonidine, beta-blocker | Elevated BP; tachycardia (beta-blocker withdrawal) | Restart discontinued agent; taper properly |
| Substance-induced | “Used cocaine,” “took diet pills” | Recent stimulant use; decongestants; NSAIDs | Elevated BP; tachycardia; dilated pupils (stimulants) | Supportive care; benzodiazepines for stimulant-induced |
Can’t-miss / urgent#
| Diagnosis | Keywords patients use | Key clues | Focused exam clues | Initial next step |
|---|---|---|---|---|
| Hypertensive encephalopathy | “Worst headache,” “confused,” “can’t see right” | Severe HTN + neurologic symptoms | Altered mental status; papilledema; focal deficits | ED now; IV antihypertensives; imaging |
| Acute stroke | “Weak on one side,” “face drooping,” “can’t talk” | Sudden focal deficits; severe HTN | Focal neurologic deficits; asymmetric exam | ED now; stroke protocol |
| Aortic dissection | “Tearing pain,” “ripping,” “worst pain” | Sudden severe chest/back pain; HTN | BP differential between arms; new AR murmur; pulse deficits | ED now; CT angiography |
| Acute coronary syndrome | “Chest pressure,” “squeezing,” “can’t breathe” | Chest pain with severe HTN | Diaphoresis; S4; may have normal exam | ED now; ECG; troponin |
| Acute pulmonary edema | “Can’t breathe,” “drowning” | Dyspnea; orthopnea; severe HTN | Crackles; JVD; S3; hypoxia | ED now; IV diuretics; oxygen |
| Acute kidney injury | “Not urinating,” “blood in urine” | Oliguria; hematuria; rising Cr | Edema; may have flank tenderness | ED if severe; urgent nephrology |
Workup#
In-office (all patients with BP >180/120):
- Confirm BP with proper technique; repeat after 5 minutes rest
- ECG: LVH, ischemic changes, arrhythmia
- Basic labs: BMP (Cr, K), UA (proteinuria, hematuria)
Additional based on presentation:
- If chest pain: ECG; consider ED for troponin
- If neurologic symptoms: ED for imaging
- If new/worsening renal function: urgent nephrology referral
When to consider secondary HTN workup:
- Resistant HTN (uncontrolled on 3+ agents including diuretic)
- Onset before age 30 or after age 55
- Sudden worsening of previously controlled HTN
- Hypokalemia (primary aldosteronism)
- Renal bruit, flash pulmonary edema, worsening renal function with ACE-I/ARB (renal artery stenosis)
- Paroxysmal HTN with headache, palpitations, diaphoresis (pheochromocytoma)
- OSA symptoms (snoring, daytime somnolence, witnessed apneas)
When NOT to do extensive workup:
- Clear precipitant (non-adherence, pain, anxiety) with no end-organ symptoms
- Known chronic severe HTN at baseline with no acute change
- Asymptomatic with normal exam and labs
Initial management#
Hypertensive urgency (no end-organ damage):
- Goal: reduce BP gradually over 24–48 hours (not minutes)
- Rapid reduction can cause stroke, MI, or renal ischemia
- Restart/adjust oral medications; observe in office 1–2 hours
- Discharge target: BP trending down (any reduction) and <180/110; patient asymptomatic
- Do NOT use sublingual nifedipine (unpredictable, dangerous drops)
- Dialysis patients: coordinate with nephrology; may need urgent dialysis if volume overloaded
Hypertensive emergency (end-organ damage):
- ED transfer for IV antihypertensives and monitoring
- Do NOT attempt to manage in office
Address precipitants:
- Restart missed medications
- Treat pain, anxiety
- Discontinue offending agents (NSAIDs, decongestants)
- Substance use: supportive care; benzodiazepines for stimulant-induced
Management by diagnosis#
Hypertensive urgency (asymptomatic severe HTN)#
Education:
- Very high blood pressure without symptoms is concerning but not an emergency
- Goal is to lower BP safely over 1–2 days, not immediately
- Taking medications consistently is the most important thing you can do
- Untreated severe HTN increases risk of stroke, heart attack, kidney damage over time
Treatment:
Immediate office management:
- Rest in quiet room for 15–30 minutes; recheck BP
- If on medications: give usual dose if due, or add/increase agent
- Observe 1–2 hours; recheck BP every 30 minutes
- Discharge criteria: BP trending down AND <180/110 AND asymptomatic
- If BP not improving after 2 hours or symptoms develop → ED
Oral agents for acute BP lowering (choose based on comorbidities):
| Drug | Dose | Contraindications | Monitoring | Cost | Notes |
|---|---|---|---|---|---|
| Clonidine | 0.1–0.2 mg PO; may repeat in 1 hour (max 0.6 mg) | Bradycardia; AV block | HR, BP, sedation | $ | Rapid onset (30–60 min); causes sedation; must taper to discontinue |
| Captopril | 25 mg PO; may repeat in 1–2 hours | Angioedema; bilateral RAS; pregnancy; K >5.5 | BP, Cr, K | $ | Onset 15–30 min; avoid if volume depleted |
| Labetalol | 200–400 mg PO | Severe bradycardia; AV block; asthma; decompensated HF | HR, BP | $ | Onset 1–2 hours; good if tachycardic |
| Amlodipine | 5–10 mg PO | Severe AS; hypotension | BP, HR, edema | $ | Slow onset (6–12 hours); better for long-term adjustment |
| Hydralazine | 25 mg PO; may repeat in 4–6 hours | CAD (reflex tachycardia); SLE | HR, BP | $ | Causes reflex tachycardia; pair with beta-blocker |
Long-term optimization (adjust regimen for sustained control):
| Drug | Dose | Contraindications | Monitoring | Cost | Notes |
|---|---|---|---|---|---|
| Lisinopril | 10–40 mg daily | Angioedema; bilateral RAS; pregnancy | Cr, K at 1–2 weeks | $ | First-line; especially if DM, CKD, HF |
| Amlodipine | 5–10 mg daily | Severe AS | BP; ankle edema | $ | First-line; good for elderly, Black patients |
| Chlorthalidone | 12.5–25 mg daily | Gout; severe hypokalemia | K, Na, Cr, uric acid | $ | Preferred thiazide-like; more potent than HCTZ |
| Losartan | 50–100 mg daily | Same as ACE-I | Cr, K | $ | ARB if ACE-I cough; less angioedema risk |
| Metoprolol succinate | 25–200 mg daily | Severe bradycardia; decompensated HF; asthma | HR, BP | $ | Add if CAD, HF, tachycardia |
| Spironolactone | 25–50 mg daily | K >5.0; severe CKD | K, Cr | $ | Add-on for resistant HTN; check K closely |
Follow-up: 1 week for BP recheck and medication adjustment; sooner if symptoms develop.
Addressing cost/access barriers:
- Many antihypertensives are $4/month at major pharmacies (lisinopril, amlodipine, metoprolol, HCTZ)
- Patient assistance programs: manufacturer programs for brand-name drugs; NeedyMeds.org, RxAssist.org
- 90-day supplies often cheaper than monthly
- If cost is barrier, prioritize: thiazide + ACE-I/ARB or CCB (all generic, cheap)
Rebound hypertension (clonidine/beta-blocker withdrawal)#
Education:
- Stopping certain BP medications suddenly can cause dangerous rebound high blood pressure
- Clonidine and beta-blockers must be tapered, not stopped abruptly
- If you run out, call for refill immediately; don’t just skip doses
Treatment:
Clonidine withdrawal:
- Restart clonidine immediately: 0.1–0.2 mg PO
- May repeat in 1 hour if needed
- Once stabilized, taper over 1–2 weeks (reduce by 0.1 mg every 3–7 days)
- Consider transitioning to longer-acting agent
Beta-blocker withdrawal:
- Restart beta-blocker at previous dose
- If unavailable, use labetalol or another beta-blocker
- Taper over 1–2 weeks when discontinuing
Follow-up: 2–3 days to ensure BP controlled; plan taper schedule.
Stimulant-induced hypertension (cocaine, amphetamines)#
Education:
- Stimulants cause blood vessels to constrict and heart to race, raising BP dangerously
- Effects usually wear off in hours, but can cause stroke or heart attack
- Avoid stimulants; if using, this is a sign to seek help
Treatment:
Acute management:
- Benzodiazepines first-line (reduce sympathetic drive)
- Avoid beta-blockers alone (unopposed alpha stimulation can worsen HTN)
- If beta-blockade needed, use labetalol (combined alpha/beta) or add alpha-blocker first
| Drug | Dose | Contraindications | Monitoring | Cost | Notes |
|---|---|---|---|---|---|
| Lorazepam | 1–2 mg PO/IM | Respiratory depression | Sedation, RR | $ | First-line for stimulant-induced HTN |
| Diazepam | 5–10 mg PO | Same | Same | $ | Alternative benzodiazepine |
| Labetalol | 200 mg PO | Severe bradycardia; asthma | HR, BP | $ | If beta-blockade needed; has alpha-blocking activity |
| Phentolamine | 5 mg IV | Hypotension | BP | $$ | Alpha-blocker; ED setting only |
If severe or not responding:
- ED transfer for IV management and monitoring
- Cardiology consult if chest pain or ECG changes
Follow-up: 24–48 hours if managed as outpatient; substance use counseling referral.
White coat hypertension#
Education:
- Blood pressure is high in the office but normal at home
- This is common and doesn’t always need medication
- Home monitoring helps us know your true BP
Treatment:
Diagnosis:
- Home BP monitoring: average of readings over 1–2 weeks
- Ambulatory BP monitoring (ABPM): gold standard; 24-hour average
- White coat HTN: office BP ≥130/80 but home/ABPM <130/80
Management:
- If confirmed white coat HTN: lifestyle modifications, no medications
- Monitor annually; ~15–30% progress to sustained HTN
- Treat if home BP becomes elevated
Follow-up: 3–6 months with home BP log; annual reassessment.
Resistant hypertension#
Education:
- Blood pressure remains high despite taking 3 or more medications
- Often there’s an underlying cause we can find and treat
- Medication adherence and lifestyle are still critical
Treatment:
Confirm true resistance:
- Verify adherence (pill counts, pharmacy records, direct questioning)
- Confirm proper BP measurement technique
- Rule out white coat effect with home/ambulatory monitoring
- Review for interfering substances (NSAIDs, decongestants, alcohol, licorice)
Optimize current regimen:
- Ensure includes diuretic at adequate dose (chlorthalidone preferred)
- Maximize doses before adding agents
- Consider timing (some agents better at night)
Add-on therapy:
| Drug | Dose | Contraindications | Monitoring | Cost | Notes |
|---|---|---|---|---|---|
| Spironolactone | 25–50 mg daily | K >5.0; eGFR <30 | K, Cr at 1 week, then monthly | $ | Most effective add-on for resistant HTN |
| Eplerenone | 50–100 mg daily | Same | Same | $$ | Alternative if gynecomastia with spironolactone |
| Clonidine | 0.1 mg BID–TID or patch 0.1–0.3 mg/week | Bradycardia | HR, sedation | $ | Central agent; sedation, rebound risk |
| Hydralazine | 25–100 mg TID | CAD (reflex tachycardia) | HR, BP | $ | Direct vasodilator; causes reflex tachycardia |
| Minoxidil | 5–40 mg daily | Pheochromocytoma | HR, fluid retention | $ | Potent; causes fluid retention and hirsutism |
Secondary HTN workup:
- Primary aldosteronism: aldosterone/renin ratio (hold interfering meds)
- Renal artery stenosis: renal artery duplex or CTA/MRA
- Pheochromocytoma: plasma metanephrines
- OSA: sleep study
- Thyroid: TSH
- Cushing’s: 24-hour urine cortisol or overnight dexamethasone suppression
Follow-up: 2–4 weeks after medication changes; coordinate with hypertension specialist or nephrology for resistant cases.
Follow-up#
- Hypertensive urgency: 1 week for BP recheck; adjust medications as needed
- Rebound HTN: 2–3 days; plan taper
- Stimulant-induced: 24–48 hours; substance use referral
- White coat HTN: 3–6 months with home BP log
- Resistant HTN: 2–4 weeks; consider specialist referral
Return precautions (all patients):
- Severe headache, especially “worst headache of life”
- Vision changes, confusion, difficulty speaking
- Chest pain or shortness of breath
- Weakness or numbness on one side
- Nausea/vomiting with headache
Patient instructions#
- Take your blood pressure medications every day, even if you feel fine.
- If you run out of medication, call us immediately for a refill—do not skip doses.
- Check your blood pressure at home if you have a monitor; bring the readings to your appointments.
- Reduce salt in your diet; avoid adding salt and limit processed foods.
- Avoid medications that raise blood pressure: ibuprofen, naproxen, decongestants (pseudoephedrine).
- Limit alcohol and avoid cocaine or other stimulants.
- Call or seek care immediately if you develop severe headache, vision changes, chest pain, shortness of breath, or weakness on one side of your body.
Smartphrase snippets#
Hypertensive urgency, asymptomatic: BP [X/Y] in office. No headache, vision changes, chest pain, or dyspnea. Exam without focal deficits, papilledema, or pulmonary edema. ECG: [normal/LVH]. Cr [X]. Likely [non-adherence/medication adjustment needed]. Restarted/adjusted [medication]. Observed in office with BP improving to [X/Y]. Discussed adherence, return precautions. Follow-up 1 week.Hypertensive urgency, medication non-adherence: BP [X/Y]. Patient reports missing [medication] for [duration] due to [reason]. No end-organ symptoms. Restarted [medication]. Addressed barriers to adherence. BP improved to [X/Y] after observation. Return precautions reviewed.Elevated BP, white coat effect suspected: Office BP [X/Y] but patient reports normal home readings. No end-organ symptoms. Plan: home BP monitoring x 2 weeks with log. If persistently elevated at home, will initiate/adjust therapy. If normal, will monitor annually.
Coding/billing notes#
- Document BP measurement technique and repeat readings
- Document symptom review for end-organ damage (headache, vision, chest pain, dyspnea, neuro symptoms)
- Document exam findings relevant to end-organ assessment
- If not sending to ED, document rationale (no end-organ symptoms/signs, improving with observation)
- Document adherence assessment and barriers identified
- For resistant HTN, document current regimen and adherence verification
Related pages#
Complaint pages#
- Chest Pain (complaint) — cardiac causes of hypertensive emergency
- Syncope (complaint) — may occur with severe HTN or as medication side effect
- Edema (complaint) — may indicate HF from chronic uncontrolled HTN
- Palpitations (complaint) — arrhythmias associated with HTN
Problem pages#
- Hypertension (problem) — comprehensive chronic hypertension management, medication selection by comorbidities, BP targets
- Heart Failure (problem) — end-organ consequence of chronic uncontrolled HTN